TrialJournal of neuro-oncology2018

Phase-2 trial of palbociclib in adult patients with recurrent RB1-positive glioblastoma.

Jennie W Taylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.